U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07718867) titled 'Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China' on July 13.
Brief Summary: This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Pre-diabetes...